JP Morgan Chase’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-11,700
Closed -$568K 7197
2022
Q4
$568K Buy
+11,700
New +$734K ﹤0.01% 4432
2019
Q1
Sell
-53,000
Closed -$1.69M 6031
2018
Q4
$1.69M Hold
53,000
﹤0.01% 3407
2018
Q3
$2.54M Buy
+53,000
New +$2.17M ﹤0.01% 3290

Other funds holding STAA

JP Morgan Chase's STAA Position: Q1 2026 in Review

JP Morgan Chase reduced its STAAR Surgical (STAA) stake by 25% in Q1 2026, selling an estimated $233K and leaving 37,294 shares worth $684K. The position accounts for ﹤0.01% of the portfolio, ranked #4811.

JP Morgan Chase first reported a position in STAA in Q3 2013 and has held it in 37 quarters since. The position peaked at $28.6M in Q2 2021. 187 funds tracked by Wall St. Rank hold STAA as of Q1 2026.

  • JP Morgan Chase held 37,294 shares of STAAR Surgical worth $684K as of Q1 2026.
  • JP Morgan Chase sold 12,211 STAAR Surgical shares in Q1 2026, an estimated $233K.
  • STAAR Surgical made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4811 holding.
  • JP Morgan Chase first reported a position in STAAR Surgical in Q3 2013 and has held it in 37 quarters since.
  • JP Morgan Chase's STAAR Surgical position peaked at $28.6M in Q2 2021.
  • 187 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.